Cite
HARVARD Citation
Kitahara, H. et al. (n.d.). 36PEribulin demonstrate selectively high sensitivity to recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) cells and xenograft tumors. Annals of oncology. p. . [Online].